Drug Landscape
Explore the current gene therapy drug landscape with detailed analysis of key therapies and players, including Pfizer & Spark Therapeutics’ BEQVEZ approval for Hemophilia B, and the rise of innovative gene editing technologies across both viral and non-viral systems.
Trials and Regulatory Announcements
Stay updated on the latest gene therapy trials and regulatory activities. This report covers significant trial announcements, new regulatory approvals, and the expanding application of gene editing technologies in 2024.
Emerging Trends
Understand the emerging trends reshaping gene therapy, including a shift towards common disease applications, the challenges in securing investment, and the critical importance of novel vector engineering to drive future success.
Why You Should Download This Series:
- Part 1: Drug Landscape – Explore the current gene therapy drug landscape, with in-depth analysis of key players and breakthrough therapies, including Pfizer & Spark Therapeutics’ BEQVEZ, the second AAV gene therapy approved for Hemophilia B.
- Part 2: Trials and Regulatory Announcements – Stay ahead of the curve with updates on trial activities, regulatory approvals, and new applications of gene editing technologies across viral and non-viral delivery systems.
- Part 3: Emerging Trends – Understand the emerging trends that are reshaping the gene therapy landscape, including the shift towards more common diseases and the crucial challenges developers face in securing investment and engineering novel vectors.
Why Beacon? Our series is powered by Beacon’s extensive database, offering the ability to filter and analyze over 176 unique delivery systems, 67 editing technologies, and 469 genes/mutations. Gain insights into AAV serotypes, non-viral systems, and more to benchmark your pipeline and drive confident, data-backed investment decisions.
Prepare for the future of gene therapy with the insights and data that matter. Download our H1 2024 Landscape Review Series today.
You May Also Be Interested In...
H1 2024 Immune Tolerance Landscape Review
H1 2024 RNA Landscape Review
H1 2024 Gene Therapy Landscape Review
H1 2024 Cell Therapy Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
